Home » Europe Backs New Dual-Action Novartis Lung Drug
Europe Backs New Dual-Action Novartis Lung Drug
The European Medicines Agency recommended approval of Novartis’ new inhaled bronchodilator combination QVA149.
The Economic Times
The Economic Times
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May